Trevi Therapeutics Aktie
6,28
USD
+0,27
USD
+4,49
%
6,28
USD
+0,27
USD
+4,50
%
Werbung
Trevi Therapeutics Aktie Analyse
03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung